This suggests that Ach may have therapeutic potential in nicotine-induced NSCLC cells by upregulating expression of p53, which promotes apoptosis/autophagy and reduce proliferation and angiogenesis in NSCLC cells. This evidence concerns the gene TP53 and non-small cell lung carcinoma.